Drug Shortage Report for TOBRADEX
| Report ID | 255935 |
| Drug Identification Number | 00778915 |
| Brand name | TOBRADEX |
| Common or Proper name | TOBRADEX OINTMENT 3.5G |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE TOBRAMYCIN |
| Strength(s) | 0.1% 0.3% |
| Dosage form(s) | OINTMENT |
| Route of administration | OPHTHALMIC OPHTHALMIC |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 3.5G |
| ATC code | S01CA |
| ATC description | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-04-28 |
| Actual start date | 2025-04-28 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-04-29 | English | Compare |
| v2 | 2025-04-28 | French | Compare |
| v1 | 2025-04-28 | English | Compare |
Showing 1 to 3 of 3